Stockholm - Delayed Quote SEK

LIDDS AB (publ) (LIDDS.ST)

0.0410
0.0000
(0.00%)
At close: May 21 at 5:29:40 PM GMT+2
Currency in SEK All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
1,888
3,554
Cost of Revenue
--
-32
--
--
--
Gross Profit
--
32
--
--
--
Operating Expense
22,674
4,537
40,674
38,506
40,824
Operating Income
-22,642
-4,505
-40,674
-36,618
-37,270
Net Non Operating Interest Income Expense
692
206
468
-243
0
Pretax Income
-21,952
-4,299
-40,206
-36,860
-37,270
Tax Provision
--
12
--
--
--
Net Income Common Stockholders
-21,959
-4,311
-40,206
-36,860
-37,270
Diluted NI Available to Com Stockholders
-21,959
-4,311
-40,206
-36,860
-37,270
Basic EPS
-0.04
--
-0.63
-1.07
-1.08
Diluted EPS
-0.04
--
-0.63
-1.07
-1.08
Basic Average Shares
121,793.5180
--
63,456
34,396
34,441.9530
Diluted Average Shares
136,463.3260
--
63,456
34,396
34,441.9530
Total Operating Income as Reported
-22,642
-4,505
-40,674
-36,617
-37,269
Total Expenses
22,642
4,505
40,674
38,506
40,824
Net Income from Continuing & Discontinued Operation
-21,959
-4,311
-40,206
-36,860
-37,270
Normalized Income
-21,959
-4,311
-40,206
-36,860
-37,270
Interest Income
793
307
529
19
0
Interest Expense
101
101
61
262
0
Net Interest Income
692
206
468
-243
0
EBIT
-21,851
-4,198
-40,145
-36,598
-37,270
EBITDA
-5,913
-3,682
-24,457
-36,114
-36,806
Reconciled Cost of Revenue
--
-32
--
--
--
Reconciled Depreciation
-178
-387
475
484
464
Net Income from Continuing Operation Net Minority Interest
-21,959
-4,311
-40,206
-36,860
-37,270
Normalized EBITDA
-5,913
-3,682
-24,457
-36,114
-36,806
Tax Rate for Calcs
0
0.0002
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 7/31/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

NANECH.ST NanoEcho AB
0.1088
-1.09%
 
GUARD.ST Guard Therapeutics International AB (publ)
15.30
+1.32%
 
LPGO.ST Lipigon Pharmaceuticals AB (publ)
0.0956
+0.63%
 
QUIA.ST Quia Pharma AB (publ)
0.0081
-1.22%
 
XINT.ST Xintela AB (publ)
0.4940
0.00%
 
2CUREX.ST 2cureX AB (publ)
1.9400
+11.82%
 
SCOL.ST Scandion Oncology A/S
0.0187
+9.36%
 
GENO.ST Genovis AB (publ.)
25.65
+4.91%
 
ACTI.ST Active Biotech AB (publ)
0.1700
+44.31%
 
XSPRAY.ST Xspray Pharma AB (publ)
30.80
+1.65%